Cargando…

An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides

Heterocycle-containing cyclic peptides are promising scaffolds for the pharmaceutical industry but their chemical synthesis is very challenging. A new universal method has been devised to prepare these compounds by using a set of engineered marine-derived enzymes and substrates obtained from a famil...

Descripción completa

Detalles Bibliográficos
Autores principales: Houssen, Wael E, Bent, Andrew F, McEwan, Andrew R, Pieiller, Nathalie, Tabudravu, Jioji, Koehnke, Jesko, Mann, Greg, Adaba, Rosemary I, Thomas, Louise, Hawas, Usama W, Liu, Huanting, Schwarz-Linek, Ulrich, Smith, Margaret C M, Naismith, James H, Jaspars, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282754/
https://www.ncbi.nlm.nih.gov/pubmed/25331823
http://dx.doi.org/10.1002/anie.201408082
_version_ 1782351174982172672
author Houssen, Wael E
Bent, Andrew F
McEwan, Andrew R
Pieiller, Nathalie
Tabudravu, Jioji
Koehnke, Jesko
Mann, Greg
Adaba, Rosemary I
Thomas, Louise
Hawas, Usama W
Liu, Huanting
Schwarz-Linek, Ulrich
Smith, Margaret C M
Naismith, James H
Jaspars, Marcel
author_facet Houssen, Wael E
Bent, Andrew F
McEwan, Andrew R
Pieiller, Nathalie
Tabudravu, Jioji
Koehnke, Jesko
Mann, Greg
Adaba, Rosemary I
Thomas, Louise
Hawas, Usama W
Liu, Huanting
Schwarz-Linek, Ulrich
Smith, Margaret C M
Naismith, James H
Jaspars, Marcel
author_sort Houssen, Wael E
collection PubMed
description Heterocycle-containing cyclic peptides are promising scaffolds for the pharmaceutical industry but their chemical synthesis is very challenging. A new universal method has been devised to prepare these compounds by using a set of engineered marine-derived enzymes and substrates obtained from a family of ribosomally produced and post-translationally modified peptides called the cyanobactins. The substrate precursor peptide is engineered to have a non-native protease cleavage site that can be rapidly cleaved. The other enzymes used are heterocyclases that convert Cys or Cys/Ser/Thr into their corresponding azolines. A macrocycle is formed using a macrocyclase enzyme, followed by oxidation of the azolines to azoles with a specific oxidase. The work is exemplified by the production of 17 macrocycles containing 6–9 residues representing 11 out of the 20 canonical amino acids.
format Online
Article
Text
id pubmed-4282754
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher WILEY-VCH Verlag
record_format MEDLINE/PubMed
spelling pubmed-42827542015-01-15 An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides Houssen, Wael E Bent, Andrew F McEwan, Andrew R Pieiller, Nathalie Tabudravu, Jioji Koehnke, Jesko Mann, Greg Adaba, Rosemary I Thomas, Louise Hawas, Usama W Liu, Huanting Schwarz-Linek, Ulrich Smith, Margaret C M Naismith, James H Jaspars, Marcel Angew Chem Int Ed Engl Communications Heterocycle-containing cyclic peptides are promising scaffolds for the pharmaceutical industry but their chemical synthesis is very challenging. A new universal method has been devised to prepare these compounds by using a set of engineered marine-derived enzymes and substrates obtained from a family of ribosomally produced and post-translationally modified peptides called the cyanobactins. The substrate precursor peptide is engineered to have a non-native protease cleavage site that can be rapidly cleaved. The other enzymes used are heterocyclases that convert Cys or Cys/Ser/Thr into their corresponding azolines. A macrocycle is formed using a macrocyclase enzyme, followed by oxidation of the azolines to azoles with a specific oxidase. The work is exemplified by the production of 17 macrocycles containing 6–9 residues representing 11 out of the 20 canonical amino acids. WILEY-VCH Verlag 2014-12-15 2014-10-21 /pmc/articles/PMC4282754/ /pubmed/25331823 http://dx.doi.org/10.1002/anie.201408082 Text en © 2014 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Communications
Houssen, Wael E
Bent, Andrew F
McEwan, Andrew R
Pieiller, Nathalie
Tabudravu, Jioji
Koehnke, Jesko
Mann, Greg
Adaba, Rosemary I
Thomas, Louise
Hawas, Usama W
Liu, Huanting
Schwarz-Linek, Ulrich
Smith, Margaret C M
Naismith, James H
Jaspars, Marcel
An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides
title An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides
title_full An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides
title_fullStr An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides
title_full_unstemmed An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides
title_short An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides
title_sort efficient method for the in vitro production of azol(in)e-based cyclic peptides
topic Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282754/
https://www.ncbi.nlm.nih.gov/pubmed/25331823
http://dx.doi.org/10.1002/anie.201408082
work_keys_str_mv AT houssenwaele anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT bentandrewf anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT mcewanandrewr anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT pieillernathalie anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT tabudravujioji anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT koehnkejesko anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT manngreg anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT adabarosemaryi anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT thomaslouise anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT hawasusamaw anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT liuhuanting anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT schwarzlinekulrich anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT smithmargaretcm anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT naismithjamesh anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT jasparsmarcel anefficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT houssenwaele efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT bentandrewf efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT mcewanandrewr efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT pieillernathalie efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT tabudravujioji efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT koehnkejesko efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT manngreg efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT adabarosemaryi efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT thomaslouise efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT hawasusamaw efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT liuhuanting efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT schwarzlinekulrich efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT smithmargaretcm efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT naismithjamesh efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides
AT jasparsmarcel efficientmethodfortheinvitroproductionofazolinebasedcyclicpeptides